2018
DOI: 10.1016/j.jsbmb.2017.12.008
|View full text |Cite
|
Sign up to set email alerts
|

Longitudinal serum and urine steroid metabolite profiling in a 46,XY infant with prenatally identified POR deficiency

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

3
1
0

Year Published

2019
2019
2023
2023

Publication Types

Select...
3
3
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(4 citation statements)
references
References 19 publications
3
1
0
Order By: Relevance
“…4 D ). This result corroborates a previous report on urine steroid metabolite excretion in a 46,XY infant affected by PORD, which also described increased 5α-androsterone but unremarkable etiocholanolone excretion (38). Of note, the POR A287P-homozygous patients in our study had higher excretion of 5α-17HP and 5α-androsterone than the compound-heterozygous patient, who can be expected to have less alternative pathway activity due to the greater impairment of residual POR function.…”
Section: Resultssupporting
confidence: 92%
“…4 D ). This result corroborates a previous report on urine steroid metabolite excretion in a 46,XY infant affected by PORD, which also described increased 5α-androsterone but unremarkable etiocholanolone excretion (38). Of note, the POR A287P-homozygous patients in our study had higher excretion of 5α-17HP and 5α-androsterone than the compound-heterozygous patient, who can be expected to have less alternative pathway activity due to the greater impairment of residual POR function.…”
Section: Resultssupporting
confidence: 92%
“…This result corroborates a previous report on urine steroid metabolite excretion in a 46,XY infant affected by PORD, which also described increased 5α-androsterone but unremarkable etiochaolanolone excretion (38). Of note, the POR A287P homozygous patients in our study had higher excretion of 5α-17HP and 5αandrosterone than the compound heterozygous patient, who can be expected to have less alternative pathway activity due to the greater impairment of residual POR function.…”
Section: Androgen Biosynthesis In Neonates With Congenital Adrenal Hysupporting
confidence: 92%
“…4D). This result corroborates a previous report on urine steroid metabolite excretion in a 46,XY infant affected by PORD, which also described increased 5α-androsterone but unremarkable etiocholanolone excretion (38). Of note, the POR A287P-homozygous patients in our study had higher excretion of 5α-17HP and 5α-androsterone than the compound-heterozygous patient, who can be expected to have less alternative pathway activity due to the greater impairment of residual POR function.…”
Section: Androgen Biosynthesis In Neonates With Congenital Adrenalsupporting
confidence: 92%